Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B Net Income

As of the most recent data (June 2026), BDXB shows a net income of $940M. That compares with $1.6B in the prior-year period — down 40.6% year over year. That is below the Healthcare sector average of $16B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BDXB's net income is now $940M (was $1.6B) — a 40.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B is outperforming or lagging.

The Healthcare sector average net income is about $16B. Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B is at $940M, which is lower that average. That is roughly 94.3% below the sector mean. Use the comparison chart on this page to see how BDXB stacks up against individual peers as well.

Tracking BDXB's net income over time shows whether Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B is scaling, shrinking, or reshaping that part of the business. The current reading is $940M That compares with $1.6B in the prior-year period — down 40.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net income page, Stockcircle has Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $940M) with ownership activity and broader fundamentals.